Pulmonary Hypertension News

Pulmonary Hypertension News Your source for pulmonary hypertension news, support, & real stories from the community. Let's raise awareness together!🎗️

Pulmonary Hypertension News is a leading online health, science, and research publication, focused on delivering daily news and information about PH to those affected by the disease, as well as providing first-hand perspectives from members of the patient community. Our news and information articles are written by a dedicated team of science writers, curated, fact-checked, and edited by a team of

PhD researchers and experienced journalists whose sole focus is ensuring our news and information is accurate, timely, relevant, and easy to understand. Our columns are written by PH patients and caregivers who provide an intimate look at what it’s like to live with PH. Their stories offer a realistic first-hand account of various aspects of the disease, in addition to providing inspiration and hope to our patient communities.

👀See what matters: https://bit.ly/46hCFSY🫶 Finding strength in chronic pain isn’t easy—but acceptance and self-advocacy ...
09/26/2025

👀See what matters: https://bit.ly/46hCFSY

🫶 Finding strength in chronic pain isn’t easy—but acceptance and self-advocacy help open up new ways to live and cope.

💪 Acceptance doesn’t mean giving up—instead, it opens the door to adapting, self-advocacy, and hope for better days. This powerful personal story for Pain Awareness Month is a reminder that your struggles are real, your resilience is seen, and you are not alone: https://bit.ly/46hCFSY

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT23...
09/26/2025

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.

🌍 Today on , we join the global community in raising awareness for lung health.🫁 For people living with pulmonary hyper...
09/25/2025

🌍 Today on , we join the global community in raising awareness for lung health.

🫁 For people living with pulmonary hypertension, protecting and maintaining lung function is central to everyday life. From treatments and therapies to the power of community support, every step matters in the journey toward healthier lungs.

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, i...
09/24/2025

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, in a long-term study.

❓Are you on supplemental oxygen? https://bit.ly/4nmutqGEver worry about getting stranded if your car breaks down—or how ...
09/24/2025

❓Are you on supplemental oxygen? https://bit.ly/4nmutqG

Ever worry about getting stranded if your car breaks down—or how to prepare for unexpected situations? Share your tips, read advice from the PH community, and connect with others who get it.

Join the conversation and find support in our forums: https://bit.ly/4nmutqG

Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blin...
09/22/2025

Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blindness, per a study.

👀 Take a closer look: https://bit.ly/46d6zYnTenax Therapeutics just secured a new European patent to protect its oral dr...
09/22/2025

👀 Take a closer look: https://bit.ly/46d6zYn

Tenax Therapeutics just secured a new European patent to protect its oral drug levosimendan (TNX-103) and related formulas for treating pulmonary hypertension linked to heart failure with preserved ejection fraction (PH-HFpEF).

👍This means future access to innovative treatment options may be expanding—especially as new clinical trials get underway across Europe.

Learn how this milestone could unlock better care for the underserved PH-HFpEF community: https://bit.ly/46d6zYn

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Eur...
09/19/2025

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Europe.

🎧 Tune in to episode 538 of the Phaware Global Association Podcast for an in-depth conversation with Dr. John Kingrey—a...
09/19/2025

🎧 Tune in to episode 538 of the Phaware Global Association Podcast for an in-depth conversation with Dr. John Kingrey—a leader in pulmonary hypertension care.

Dr. Kingrey shares cutting-edge insights and compassionate perspectives on diagnosing, treating, and supporting people living with PH. If PH affects you or someone you love, don’t miss this expert-led discussion for the latest knowledge and hope.

Listen now: https://phawarepodcast.libsyn.com/site/episode-525-john-kingrey-md

💬 Meet Our PH Advocates 👋 https://bit.ly/4n9VD3O🌷Anna's art and writing is centered on grief, survival, and the hope th...
09/19/2025

💬 Meet Our PH Advocates 👋 https://bit.ly/4n9VD3O

🌷Anna's art and writing is centered on grief, survival, and the hope that continues to bloom amidst these circumstances.

🫶 In her column, “Life as a Caregiver,” Colleen is open and honest about caring for her son, his PH experiences, and life post-transplant.

💪 Jolie hopes to bring raw truth and vulnerability to her column - The PHlip-side

🎢 In her weekly column, Worth the PHight, Jen delves into the roller coaster of emotions that accompany PH.

📖 Read their stories here: https://bit.ly/4n9VD3O

🎧 https://bit.ly/4gx0fOY 🎧 A new podcast series from Phaware Global Association, I'm Aware That I'm Rare: the phaware ...
09/17/2025

🎧 https://bit.ly/4gx0fOY 🎧 A new podcast series from Phaware Global Association, I'm Aware That I'm Rare: the phaware podcast is spotlighting the rise of methamphetamine-associated pulmonary arterial hypertension (Meth-PAH)—a critical but often overlooked cause of severe lung disease.

Through weekly episodes, leading doctors and community voices share the science, stories, and challenges behind Meth-PAH, tackling both stigma and survival. If you or someone you care about is affected, this series is a must-listen for real talk and practical hope.

New episodes launch every Tuesday: https://bit.ly/4gx0fOY

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people wit...
09/17/2025

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people with PAH and PH-ILD.

Address

Dallas, TX

Website

Alerts

Be the first to know and let us send you an email when Pulmonary Hypertension News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category

Our Story

Pulmonary Hypertension (PH) is a relatively rare disease, and certainly not a household term that many people are familiar with. And yet, the research community is highly active in pursuing PH research and developing novel treatments for the disease. Pulmonary Hypertension News is a digital news publication dedicated to offering comprehensive daily news coverage of the science, medicine, and human interest stories surrounding the effects of the disease, as well as the effort underway to treat and eventually cure it. The editors at Pulmonary Hypertension News are committed to sourcing and covering PH stories on a daily basis, creating the first and only 24-hour news cycle for the disease. Between groundbreaking research in the lab, critical findings in clinical trials for novel PH therapies, game-changing funding announcements for furthering PH R&D, and heartwarming human interest stories that highlight the powerful Pulmonary Hypertension support community, there is enough news each day to keep PH patients, their families, and other researchers informed on the progress being made in treating and curing the disease.